AKT1 and neuroblastoma: NB cells show high dependency on BCL2 expression (Figure 6a), and remarkable sensitivity to the BCL inhibitor ABT-737 [279] and the AKT/BCL2 inhibitor oridonin [281] (Figure 6b).